Wordt geladen...
Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial
BACKGROUND: Sudden sensorineural hearing loss (SSHL) is a common condition in which patients lose the hearing in one ear within 3 days. Systemic glucocorticoid treatments have been used as standard therapy for SSHL; however, about 20% of patients do not respond. We tested the safety and efficacy of...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3000370/ https://ncbi.nlm.nih.gov/pubmed/21108784 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-8-76 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|